The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Marcus J. Schultz

Department of Intensive Care

Academic Medical Center

University of Amsterdam

Amsterdam

the Netherlands -

[email]@amc.uva.nl

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Intensive Care, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands -. 1998 - 2012
  • Laboratory of Experimental Internal Medicine, Department of Intensive Care Medicine, Tropical Medicine and AIDS, Academic Medical Center, Netherlands. 2001 - 2004

References

  1. Adoption and implementation of the original strict glycemic control guideline is feasible and safe in adult critically ill patients. Schultz, M.J., Harmsen, R.E., Korevaar, J.C., Abu-Hanna, A., Van Braam Houckgeest, F., Van Der Sluijs, J.P., Spronk, P.E. Minerva. Anestesiol (2012) [Pubmed]
  2. Antibiotics or probiotics as preventive measures against ventilator-associated pneumonia: a literature review. Schultz, M.J., Haas, L.E. Crit. Care (2011) [Pubmed]
  3. Clinical review: Strict or loose glycemic control in critically ill patients--implementing best available evidence from randomized controlled trials. Schultz, M.J., Harmsen, R.E., Spronk, P.E. Crit. Care (2010) [Pubmed]
  4. Survey into blood glucose control in critically ill adult patients in the Netherlands. Schultz, M.J., Binnekade, J.M., Harmsen, R.E., de Graaff, M.J., Korevaar, J.C., van Braam Houckgeest, F., van der Sluijs, J.P., Kieft, H., Spronk, P.E. Neth. J. Med (2010) [Pubmed]
  5. Evidence lost to treatment of critically-ill patients? Schultz, M.J., Spronk, P.E., Afessa, B., Gajic, O. Minerva. Anestesiol (2009) [Pubmed]
  6. A breathtaking and bloodcurdling story of coagulation and inflammation in acute lung injury. Schultz, M.J., Dixon, B. J. Thromb. Haemost. (2009) [Pubmed]
  7. Practice of strict glycemic control in critically ill patients. Schultz, M.J., de Graaff, M.J., Royakkers, A.A., van Braam Houckgeest, F., van der Sluijs, J.P., Kieft, H., Spronk, P.E. Med. Sci. Monit. (2008) [Pubmed]
  8. Lung-protective mechanical ventilation with lower tidal volumes in patients not suffering from acute lung injury: a review of clinical studies. Schultz, M.J. Med. Sci. Monit. (2008) [Pubmed]
  9. PCT and sTREM-1: the markers of infection in critically ill patients?. Schultz, M.J., Determann, R.M. Med. Sci. Monit. (2008) [Pubmed]
  10. What tidal volumes should be used in patients without acute lung injury?. Schultz, M.J., Haitsma, J.J., Slutsky, A.S., Gajic, O. Anesthesiology (2007) [Pubmed]
  11. Year in review 2006: Critical Care--Resource management. Schultz, M.J., Kuiper, M., Spronk, P.E., Vroom, M.B., Gajic, O. Crit. Care (2007) [Pubmed]
  12. Intensive insulin therapy in intensive care: an example of the struggle to implement evidence-based medicine. Schultz, M.J., Royakkers, A.A., Levi, M., Moeniralam, H.S., Spronk, P.E. PLoS Med. (2006) [Pubmed]
  13. N-acetylcysteine and other preventive measures for contrast-induced nephropathy in the intensive care unit. Schultz, M.J., Baas, M.C., van der Sluijs, H.P., Stamkot, G.A., Smit, W. Curr. Med. Chem. (2006) [Pubmed]
  14. Struggle for implementation of new strategies in intensive care medicine: anticoagulation, insulin, and lower tidal volumes. Schultz, M.J., Wolthuis, E.K., Moeniralam, H.S., Levi, M. J. Crit. Care (2005) [Pubmed]
  15. Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Schultz, M.J., Millo, J., Levi, M., Hack, C.E., Weverling, G.J., Garrard, C.S., van der Poll, T. Thorax (2004) [Pubmed]
  16. Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis. Schultz, M.J. J. Antimicrob. Chemother. (2004) [Pubmed]
  17. Interleukin-18 impairs the pulmonary host response to Pseudomonas aeruginosa. Schultz, M.J., Knapp, S., Florquin, S., Pater, J., Takeda, K., Akira, S., van der Poll, T. Infect. Immun. (2003) [Pubmed]
  18. Selective decontamination of the digestive tract reduces mortality in critically ill patients. Schultz, M.J., de Jonge, E., Kesecioglu, J. Crit. Care (2003) [Pubmed]
  19. Role of interleukin-1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia. Schultz, M.J., Rijneveld, A.W., Florquin, S., Edwards, C.K., Dinarello, C.A., van der Poll, T. Am. J. Physiol. Lung Cell Mol. Physiol. (2002) [Pubmed]
  20. Modulation of pulmonary innate immunity during bacterial infection: animal studies. Schultz, M.J., van der Poll, T. Arch. Immunol. Ther. Exp. (Warsz.) (2002) [Pubmed]
  21. Animal and human models for sepsis. Schultz, M.J., van der Poll, T. Ann. Med. (2002) [Pubmed]
  22. Mice lacking the multidrug resistance protein 1 are resistant to Streptococcus pneumoniae-induced pneumonia. Schultz, M.J., Wijnholds, J., Peppelenbosch, M.P., Vervoordeldonk, M.J., Speelman, P., van Deventer, S.J., Borst, P., van der Poll, T. J. Immunol. (2001) [Pubmed]
  23. Erythromycin inhibits Pseudomonas aeruginosa-induced tumour necrosis factor-alpha production in human whole blood. Schultz, M.J., Speelman, P., van der Poll, T. J. Antimicrob. Chemother. (2001) [Pubmed]
  24. Reduced ex vivo chemokine production by polymorphonuclear cells after in vivo exposure of normal humans to endotoxin. Schultz, M.J., Olszyna, D.P., de Jonge, E., Verbon, A., van Deventer, S.J., van der Poll, T. J. Infect. Dis. (2000) [Pubmed]
  25. The effect of pseudomonas exotoxin A on cytokine production in whole blood exposed to Pseudomonas aeruginosa. Schultz, M.J., Speelman, P., Zaat, S.A., Hack, C.E., van Deventer, S.J., van der Poll, T. FEMS Immunol. Med. Microbiol. (2000) [Pubmed]
  26. Erythromycin inhibits tumor necrosis factor alpha and interleukin 6 production induced by heat-killed Streptococcus pneumoniae in whole blood. Schultz, M.J., Speelman, P., Zaat, S., van Deventer, S.J., van der Poll, T. Antimicrob. Agents Chemother. (1998) [Pubmed]
 
WikiGenes - Universities